SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.87+1.3%Feb 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tharos who wrote (8900)3/2/1999 10:58:00 AM
From: aknahow  Read Replies (1) of 17367
 
While XOMA and Connetics compete potentially for the psoriasis market, they have an agreement in the T Cell area. I am happy to see Connectics strengthened as it might mean they are better able to carry on programs in which XOMA is involved.

The performance of Connectics has been super. Instead of XOMA one could have bought a lot of it at $3 1/2. For all the wrong reasons I did not! Thought XOMA had much more promise.<g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext